Kefeng Pu

806 total citations
21 papers, 634 citations indexed

About

Kefeng Pu is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Kefeng Pu has authored 21 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Biomedical Engineering and 6 papers in Cancer Research. Recurrent topics in Kefeng Pu's work include RNA Interference and Gene Delivery (5 papers), Cancer Cells and Metastasis (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Kefeng Pu is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Cancer Cells and Metastasis (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Kefeng Pu collaborates with scholars based in China, Australia and United States. Kefeng Pu's co-authors include Yimin Zhu, Chen Ding, Anxin Wang, Chunlin Li, Wei Duan, Yang Liu, Liming Zhang, Zhijun Zhang, Bing Dong and Yaqing Jin and has published in prestigious journals such as Nature Communications, ACS Nano and PLoS ONE.

In The Last Decade

Kefeng Pu

20 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kefeng Pu China 12 310 179 179 153 121 21 634
Tianjiao Chu China 9 222 0.7× 164 0.9× 75 0.4× 89 0.6× 140 1.2× 19 523
Derek Reichel United States 10 205 0.7× 208 1.2× 67 0.4× 86 0.6× 180 1.5× 18 508
Bilan Wang China 13 248 0.8× 265 1.5× 60 0.3× 148 1.0× 187 1.5× 18 659
Ibrahim El‐Serafi Sweden 12 178 0.6× 150 0.8× 67 0.4× 158 1.0× 147 1.2× 31 593
Lipeng Gao China 13 247 0.8× 218 1.2× 287 1.6× 97 0.6× 195 1.6× 17 679
Lu Guo China 17 341 1.1× 202 1.1× 80 0.4× 63 0.4× 167 1.4× 33 595
Ali Tarighatnia Iran 11 298 1.0× 153 0.9× 89 0.5× 71 0.5× 152 1.3× 32 576

Countries citing papers authored by Kefeng Pu

Since Specialization
Citations

This map shows the geographic impact of Kefeng Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Pu more than expected).

Fields of papers citing papers by Kefeng Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefeng Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Pu. The network helps show where Kefeng Pu may publish in the future.

Co-authorship network of co-authors of Kefeng Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Kefeng Pu. A scholar is included among the top collaborators of Kefeng Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefeng Pu. Kefeng Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Ye, Xuewen Zheng, Yongyong Shi, et al.. (2025). Enhancing Immune Responses and Tumor Inhibition with Iron Oxide Nanoparticle Adjuvants. Chemistry of Materials. 37(9). 3555–3563. 1 indexed citations
2.
Xu, Jing, et al.. (2025). Cynaroside alleviates radiation-induced intestinal injury by inhibiting dynamin 2. International Immunopharmacology. 162. 115167–115167. 1 indexed citations
3.
Jiang, Min, Jingyi Qin, Ye Shen, et al.. (2025). Lab-in-a-Tip: a multiplex immunoassay platform based on a self-assembled barcoded protein array. Nature Communications. 16(1). 3990–3990.
4.
Ge, Fang, Xiaomei Shen, Yu‐Chen Chang, et al.. (2025). Modulation of Bacterial Iron Homeostasis to Enhance Cuproptosis-like Death for the Treatment of Infected Diabetic Wound. ACS Nano. 19(16). 15578–15595. 3 indexed citations
5.
Zhang, Jingjing, Shuangshuang Wan, Xu Wang, et al.. (2024). Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes. Nature Nanotechnology. 20(1). 156–166. 25 indexed citations
6.
Shi, Yongyong, et al.. (2024). Proapoptotic Peptide-Templated Au Nanoclusters Selectively Enhance Radiosensitivity of Cancer Cells. Chemistry of Materials. 1 indexed citations
7.
Shi, Ying, Kefeng Pu, Haodong Yao, et al.. (2023). Gold Nanorods Inhibit Tumor Metastasis by Regulating MMP-9 Activity: Implications for Radiotherapy. ACS Applied Materials & Interfaces. 15(7). 9034–9043. 5 indexed citations
8.
Wang, Yuanyuan, Min Jiang, Xuewen Zheng, et al.. (2023). Application of exosome engineering modification in targeted delivery of therapeutic drugs. Biochemical Pharmacology. 215. 115691–115691. 17 indexed citations
9.
Xu, Jing, Mingzhu Wang, Qiuping Liu, et al.. (2022). Gut microbiota mediated the toxicity of high concentration of dietary nitrite in C57BL/6 mice. Ecotoxicology and Environmental Safety. 231. 113224–113224. 16 indexed citations
10.
Wang, Zhenchang, Kangkang Zhi, Yi Sun, et al.. (2020). Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force. Seminars in Cancer Biology. 69. 77–90. 35 indexed citations
11.
Shen, Ye, Kefeng Pu, Xiaochuan Ma, et al.. (2019). Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation. International Journal of Molecular Sciences. 20(18). 4473–4473. 19 indexed citations
12.
Li, Chunlin, Dayong Zhou, Chen Ding, et al.. (2018). Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis. Acta Biomaterialia. 70. 227–236. 103 indexed citations
13.
Li, Chunlin, Jundong Zhou, Chen Ding, et al.. (2017). Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy. Cancer Immunology Research. 6(2). 178–188. 140 indexed citations
14.
Pu, Kefeng, et al.. (2016). Epithelial cell adhesion molecule independent capture of non-small lung carcinoma cells with peptide modified microfluidic chip. Biosensors and Bioelectronics. 89(Pt 2). 927–931. 18 indexed citations
15.
Jin, Yaqing, et al.. (2016). Nanosystem composed with MSNs, gadolinium, liposome and cytotoxic peptides for tumor theranostics. Colloids and Surfaces B Biointerfaces. 151. 240–248. 19 indexed citations
16.
Pu, Kefeng, Lihua Yuan, Lisha Chen, et al.. (2015). Identification of VEGFR2-Binding Peptides Using High Throughput Bacterial Display Methods and Functional Assessment. Current Cancer Drug Targets. 15(2). 158–170. 6 indexed citations
17.
Wang, Anxin, Lisha Chen, Kefeng Pu, & Yimin Zhu. (2014). Identification of stem-like cells in non-small cell lung cancer cells with specific peptides. Cancer Letters. 351(1). 100–107. 16 indexed citations
18.
Dong, Bing, Anxin Wang, Lisha Chen, et al.. (2013). Peptide-Fluorescent Bacteria Complex as Luminescent Reagents for Cancer Diagnosis. PLoS ONE. 8(1). e54467–e54467. 6 indexed citations
19.
Wang, Anxin, Kefeng Pu, Bing Dong, et al.. (2013). Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. Journal of Applied Toxicology. 33(10). 1156–1164. 179 indexed citations
20.
Dong, Bing, et al.. (2012). A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer. Chinese Journal of Cancer. 31(12). 564–572. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026